Novartis, CH0012005267

Novartis stock gains 0.62 percent at the close

Published on 09/23/2026 at 22:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Novartis stock finished at USD 141.24 on the NYSE, up 0.62 percent. The S&P 500 was lower during the session, while a radioligand therapy deal shaped company news.

Forscherin in weißem Kittel pipettiert in Reagenzglas im sterilen Pharmalabor
Novartis AG CH0012005267 – Forscherin pipettiert präzise in steriler Pharmalaborumgebung mit Reagenzgläsern, Illustration mit AI erstellt.

Novartis stock, represented by the U.S.-listed ADRs, closed at USD 141.24 on the NYSE on September 23, 2026, gaining 0.62 percent from the prior close. The move contrasted with the S&P 500, which was down 0.65 percent during the session according to market data reported by Yahoo Finance.

September 23, 2026 close on the NYSE

Novartis AG (ISIN CH0012005267, NYSE: NVS) opened at USD 141.20 on September 23, 2026, according to MarketBeat. The closing price was USD 0.04 above the reported open, while the S&P 500 comparison showed a gap of 1.27 percentage points in Novartis stock's favor.

Novartis news included a reported USD 900 million radioligand therapy agreement with BoomRay, while Yahoo Finance also listed a positive regulatory opinion for Cosentyx. On the SIX, Novartis shares finished 0.98 percent higher at 11:35 a.m. ET, a different result from the U.S. ADR because of the exchange rate.

After the bell today

The U.S. extended session runs until 8:00 p.m. ET. The next U.S. trading session is September 24, 2026, with the market backdrop still focused on Treasury yields, energy prices and scheduled company reporting covered in the day's market calendar.

Disclaimer...

en | CH0012005267 | NOVARTIS | boerse | 70170342 | bgmi